Patent Watch | GenomeWeb

Patent Watch

Premium
Ocimum Biosolutions of Indianapolis has received US Patent No. 7,469,185, “Primary rat hepatocyte toxicity modeling.” The patent claims a method for determining whether a test compound is a liver toxin by: a) exposing liver tissue or liver cells to the test compound; b) preparing a normalized gene expression profile of at least ten genes for the liver tissue or liver cells; c) comparing the gene expression profile to a hepatotoxicity model; and d) scoring the comparison to determine whether the test compound is a hepatotoxin.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.